Compounds > staurosporine
Page last updated: 2024-08-23

staurosporine and 6-ketoprostaglandin f1 alpha

staurosporine has been researched along with 6-ketoprostaglandin f1 alpha in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Levine, L1
Jones, AW; Jones, SB1
Kawase, Y; Min, KR; Mue, S; Ohuchi, K; Tanabe, J; Watanabe, M1
MacDermot, J; McEwan, JR; Parsaee, H1
Descomps, B; Lobaccaro-Henri, C; Thaler-Dao, H1

Other Studies

5 other study(ies) available for staurosporine and 6-ketoprostaglandin f1 alpha

ArticleYear
Effects of the protein kinase inhibitors, staurosporine and K-252a, on PGI2 production by rat liver cells (the C-9 cell line).
    Prostaglandins, 1990, Volume: 40, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Alkaloids; Animals; Calcimycin; Carbazoles; Cell Line; Drug Synergism; Epoprostenol; Indole Alkaloids; Liver; Platelet Activating Factor; Protein Kinase C; Radioimmunoassay; Rats; Staurosporine; Tetradecanoylphorbol Acetate

1990
Phorbol ester-stimulated 6-keto-prostaglandin F1 alpha in aortas from control and aldosterone-salt rats.
    Journal of hypertension, 1995, Volume: 13, Issue:7

    Topics: 6-Ketoprostaglandin F1 alpha; Aldosterone; Alkaloids; Animals; Aorta; Calcium; Dose-Response Relationship, Drug; Hypertension; Male; Norepinephrine; Protein Kinase C; Rats; Rats, Sprague-Dawley; Sodium Chloride; Staurosporine; Tetradecanoylphorbol Acetate

1995
Suppression of interleukin-1 alpha production by protein kinase C activators in human vascular endothelial cells.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 272, Issue:2

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; 6-Ketoprostaglandin F1 alpha; Alkaloids; Cells, Cultured; Endothelium, Vascular; Humans; Interleukin-1; Isoquinolines; Lipopolysaccharides; Lyngbya Toxins; Piperazines; Protein Kinase C; Staurosporine; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha

1995
Bradykinin-induced release of PGI2 from aortic endothelial cell lines: responses mediated selectively by Ca2+ ions or a staurosporine-sensitive kinase.
    British journal of pharmacology, 1993, Volume: 110, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Alkaloids; Animals; Aorta, Thoracic; Arginine; Bradykinin; Calcium; Cattle; Cell Line; Endothelium, Vascular; Epoprostenol; Ionomycin; Nitric Oxide; omega-N-Methylarginine; Phosphotransferases; Signal Transduction; Staurosporine

1993
RU 38486 inhibits intracellular calcium mobilization and PGI2 release from human myometrium: mechanisms of action.
    The Journal of steroid biochemistry and molecular biology, 1996, Volume: 59, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Abortifacient Agents, Steroidal; Arginine Vasopressin; Calcium; Calcium Channel Blockers; Calcium-Transporting ATPases; Drug Synergism; Endoplasmic Reticulum; Enzyme Inhibitors; Epoprostenol; Female; Gallic Acid; Hormone Antagonists; Humans; Intracellular Fluid; Mifepristone; Muscle Relaxation; Myometrium; Nifedipine; Phosphatidylinositol Diacylglycerol-Lyase; Phosphoric Diester Hydrolases; Staurosporine; Structure-Activity Relationship; Thapsigargin; Uterine Contraction

1996